DK0594950T3 - Pædiatrisk kombinationsvaccine med forbedret immunogenicitet af hver vaccinekomponent - Google Patents

Pædiatrisk kombinationsvaccine med forbedret immunogenicitet af hver vaccinekomponent

Info

Publication number
DK0594950T3
DK0594950T3 DK93111735T DK93111735T DK0594950T3 DK 0594950 T3 DK0594950 T3 DK 0594950T3 DK 93111735 T DK93111735 T DK 93111735T DK 93111735 T DK93111735 T DK 93111735T DK 0594950 T3 DK0594950 T3 DK 0594950T3
Authority
DK
Denmark
Prior art keywords
vaccine
pediatric
improved immunogenicity
component
combined
Prior art date
Application number
DK93111735T
Other languages
Danish (da)
English (en)
Inventor
Peter R Paradiso
Deborah A Hogerman
Dace Viceps Madore
Jill G Hackell
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK0594950T3 publication Critical patent/DK0594950T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Peptides Or Proteins (AREA)
DK93111735T 1992-10-27 1993-07-22 Pædiatrisk kombinationsvaccine med forbedret immunogenicitet af hver vaccinekomponent DK0594950T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96699592A 1992-10-27 1992-10-27

Publications (1)

Publication Number Publication Date
DK0594950T3 true DK0594950T3 (da) 1999-09-13

Family

ID=25512167

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93111735T DK0594950T3 (da) 1992-10-27 1993-07-22 Pædiatrisk kombinationsvaccine med forbedret immunogenicitet af hver vaccinekomponent

Country Status (23)

Country Link
EP (1) EP0594950B1 (ja)
JP (1) JPH07300427A (ja)
KR (1) KR100289224B1 (ja)
AT (1) ATE176157T1 (ja)
AU (1) AU669570B2 (ja)
CA (1) CA2109159A1 (ja)
CZ (1) CZ283587B6 (ja)
DE (2) DE69323264D1 (ja)
DK (1) DK0594950T3 (ja)
ES (1) ES2126616T3 (ja)
FI (1) FI934725A (ja)
GR (1) GR3029884T3 (ja)
HK (1) HK1009931A1 (ja)
HU (1) HU215149B (ja)
IL (1) IL107387A (ja)
LV (1) LV12271B (ja)
NO (1) NO308588B1 (ja)
NZ (1) NZ250029A (ja)
PL (1) PL174130B1 (ja)
RU (1) RU2121365C1 (ja)
SG (1) SG47725A1 (ja)
TW (1) TW256774B (ja)
UA (1) UA27754C2 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1864195A (en) * 1994-03-07 1995-09-25 Auckland Uniservices Limited Prevention of diabetes
CA2222455C (en) * 1995-03-22 2013-05-28 Smithkline Beecham Biologicals S.A. A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
BR9608612A (pt) * 1995-06-07 1999-05-04 Smithkline Beecham Biolog Vacina compreendendo um conjugado de antígeno de polissacarídeo - proteína portadora e proteína portadora livre
US20020054884A1 (en) 1995-06-23 2002-05-09 Smithkline Beecham Biologicals, Sa Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
EP1762246A1 (en) * 1996-07-02 2007-03-14 Sanofi Pasteur Limited Multivalent DTP-Polio vaccines
PT1296715E (pt) * 2000-06-29 2012-01-19 Smithkline Beecham Biolog Composição vacinal multivalente
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
ES2649048T3 (es) 2002-11-01 2018-01-09 Glaxosmithkline Biologicals S.A. Procedimiento de secado
GB0505996D0 (en) * 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
KR101408113B1 (ko) 2005-06-27 2014-06-16 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신 제조 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates

Also Published As

Publication number Publication date
LV12271A (lv) 1999-05-20
HK1009931A1 (en) 1999-06-11
DE69323264T4 (de) 1999-10-14
CZ227293A3 (en) 1994-05-18
AU5029093A (en) 1994-05-12
FI934725A (fi) 1994-04-28
ATE176157T1 (de) 1999-02-15
RU2121365C1 (ru) 1998-11-10
NZ250029A (en) 1994-09-27
EP0594950B1 (en) 1999-01-27
HUT67239A (en) 1995-03-28
ES2126616T3 (es) 1999-04-01
KR940008698A (ko) 1994-05-16
AU669570B2 (en) 1996-06-13
UA27754C2 (uk) 2000-10-16
JPH07300427A (ja) 1995-11-14
NO933856D0 (no) 1993-10-26
PL174130B1 (pl) 1998-06-30
LV12271B (en) 1999-07-20
CA2109159A1 (en) 1994-04-28
IL107387A0 (en) 1994-01-25
HU9303028D0 (en) 1994-01-28
FI934725A0 (fi) 1993-10-26
NO308588B1 (no) 2000-10-02
CZ283587B6 (cs) 1998-05-13
SG47725A1 (en) 1998-04-17
HU215149B (hu) 2000-03-28
GR3029884T3 (en) 1999-07-30
KR100289224B1 (ko) 2001-05-02
DE69323264D1 (de) 1999-03-11
TW256774B (ja) 1995-09-11
EP0594950A1 (en) 1994-05-04
IL107387A (en) 1997-04-15
NO933856L (no) 1994-04-28
DE69323264T2 (de) 1999-06-02

Similar Documents

Publication Publication Date Title
AU696338B2 (en) A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
BR9710460A (pt) Composi-Æo imunolÄgica multi-valente e seu uso em vacinas
IL115047A0 (en) Pneumococcal polysaccharide - recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections.
EA200501070A1 (ru) Поливалентная вакцинная композиция
FI104046B1 (fi) Menetelmä konjugoidun oligosakkaridin valmistamiseksi
NO179164C (no) Fremgangsmåte for fremstilling av et immunogenkonjugat
DK0594950T3 (da) Pædiatrisk kombinationsvaccine med forbedret immunogenicitet af hver vaccinekomponent
RU93048161A (ru) Комбинированная педиатрическая вакцина с усиленной иммуногенностью каждого вакционного компонента
DE68915046D1 (de) Haemophilus influenzae Typ B Polysaccharid-Aussermembranprotein-Konjugat als Impfstoff.
Beuvery et al. Meningococcal group C polysaccharide/tetanus toxoid conjugate as immunogen.
Isaacs Haemophilus influenzae type b immunization
Egorkov et al. Immunological activity of small doses of diphtheria and tetanus toxoids in booster immunization of children with allergically altered responsiveness and adults.
Guo et al. Studies on meningococcal polysaccharide-tetanus toxoid conjugates.
SE8400934D0 (sv) Forfarande for framstellning av lyofiliserade, adsorberade, polyvalenta vacciner